drugset / Trial / NCT04673695

A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344

NCT04673695

Phase 1 Unknown 50 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

A Clinical Trial to evaluate the Pharmacokinetics and safety of CKD-344

Timeline

Start
2020-11-13
Primary completion
2020-12-26
Completion
2021-01-02

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-344 Unknown 60 mg
Subject Edoxaban Small molecule 60 mg

Indications

No indication recorded.